NCT07371208 2026-01-27
ST-A-TN
Shanghai Jiao Tong University School of Medicine
Phase 2 Recruiting
Clinical Trials
3 trialsNCT07179783 2025-09-18
Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
Tianjin Medical University Second Hospital
Phase 2 Recruiting
NCT05351788 2023-12-14
SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Phase 2 Recruiting